Mayo Clinic's organoids, microscopic versions of organs that function like the real ones, have been used by doctors to study ...

Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer - Doctors believe new test could lead ...

Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

A recent study published in the journal Medicine has found a possible connection between low vitamin D levels and increased ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...

Ulcerative colitis (UC) is a form of inflammatory bowel ... doctors may recommend surgery. Surgical treatment of UC involves removing the colon and rectum and altering how the body passes solid ...

A RECENT study has revealed that the sequence of biologic treatments in patients with inflammatory bowel disease (IBD) significantly affects their risk of adverse clinical outcomes. Patients with IBD, ...

Dennison also describes how CRISPR screening tools will be key to further unraveling the mechanisms behind IBD. Current treatments for IBD are limited. They don't cure the disease and patients require ...